Polymorphism in the Pharmaceutical Industry 2018
DOI: 10.1002/9783527697847.ch1
|View full text |Cite
|
Sign up to set email alerts
|

Solid State and Polymorphism of the Drug Substance in the Context of Quality by Design and ICH Guidelines Q8–Q12

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 100 publications
0
10
0
Order By: Relevance
“…Regardless of numerous attempts, no anhydrous cocrystal with fumaric acid was observed, whereas a solvent-free cocrystal was obtained with its geometrical isomer, maleic acid. A PSZ−coformer stoichiometric ratio of 1 to 1 was suggested by 1 H NMR for both PSZ−MLE and PSZ−FUM cocrystals, while the cocrystals with the aliphatic dicarboxylic acids, such as adipic and succinic acid, show a PSZ−coformer stoichiometry of 2 to 1.…”
Section: ■ Resultsmentioning
confidence: 96%
See 3 more Smart Citations
“…Regardless of numerous attempts, no anhydrous cocrystal with fumaric acid was observed, whereas a solvent-free cocrystal was obtained with its geometrical isomer, maleic acid. A PSZ−coformer stoichiometric ratio of 1 to 1 was suggested by 1 H NMR for both PSZ−MLE and PSZ−FUM cocrystals, while the cocrystals with the aliphatic dicarboxylic acids, such as adipic and succinic acid, show a PSZ−coformer stoichiometry of 2 to 1.…”
Section: ■ Resultsmentioning
confidence: 96%
“…Proton Nuclear Magnetic Resonance ( 1 H NMR). 1 H NMR analysis was carried out with a Bruker DPX300 spectrometer (Bruker AG, Fallanden, Switzerland) using a proton frequency of 300.13 MHz, a 30°excitation pulse, and a recycle delay of 1 s. Spectra were recorded by the accumulation of 16 scans in deuterated DMSO. The solvent peak was used for reference, and the chemical shifts were reported to the TMS scale.…”
Section: ■ Materials and Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…Usually, different polymorphic forms possess different physicochemical and, as a consequence, biological properties (bioavailability, dissolution rate, etc. ). An undesired polymorphic transition can crucially influence the drug quality as occurred with ritonavir (the trademark is Norvir) . Therefore, an in-depth study of the polymorphism of an active pharmaceutical ingredient (API) aims not only at protecting the patent of a drug but also at choosing the most appropriate polymorphic form according to the combination of several factors such as manufacturability, stability, biological activity, reproducibility, etc. , …”
Section: Introductionmentioning
confidence: 99%